Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The landscape of antimicrobial resistance in the neonatal and multi-host pathogen group B Streptococcus: review from a One Health perspective. | Front Microbiol | 2022 | 35966683 | PubTator, text mining | PubMed |
| A broad look into the future of systemic sclerosis. | Ther Adv Musculoskelet Dis | 2022 | 35966183 | PubTator, text mining | PubMed |
| Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor. | Front Oncol | 2022 | 35965509 | PubTator, text mining | PubMed |
| The unique role of innate lymphoid cells in cancer and the hepatic microenvironment. | Cell Mol Immunol | 2022 | 35962192 | PubTator, text mining | PubMed |
| Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness. | PLoS One | 2022 | 35960749 | PubTator, text mining | PubMed |
| Neuroprotective Drug Discovery From Phytochemicals and Metabolites for CNS Viral Infection: A Systems Biology Approach With Clinical and Imaging Validation. | Front Neurosci | 2022 | 35958991 | PubTator, text mining | PubMed |
| Anaplastic lymphoma kinase-special immunity and immunotherapy. | Front Immunol | 2022 | 35958559 | PubTator, text mining | PubMed |
| Bioinformatics analysis of lncRNAs in the occurrence and development of osteosarcoma. | Transl Pediatr | 2022 | 35958002 | PubTator, text mining | PubMed |
| Wound Healing Impairment in Type 2 Diabetes Model of Leptin-Deficient Mice-A Mechanistic Systematic Review. | Int J Mol Sci | 2022 | 35955751 | PubTator, text mining | PubMed |
| Downregulation of IL-8 and IL-10 by the Activation of Ca2+-Activated K+ Channel KCa3.1 in THP-1-Derived M2 Macrophages. | Int J Mol Sci | 2022 | 35955737 | PubTator, text mining | PubMed |
| CCL18 Expression Is Higher in a Glioblastoma Multiforme Tumor than in the Peritumoral Area and Causes the Migration of Tumor Cells Sensitized by Hypoxia. | Int J Mol Sci | 2022 | 35955670 | PubTator, text mining | PubMed |
| Tertiary Lymphoid Structures as Mediators of Immunotherapy Response. | Cancers (Basel) | 2022 | 35954412 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Extracellular Vesicles as Idiopathic Pulmonary Fibrosis Microenvironment Targeted Delivery. | Cells | 2022 | 35954166 | PubTator, text mining | PubMed |
| Identification of potential key molecules and signaling pathways for psoriasis based on weighted gene co-expression network analysis. | World J Clin Cases | 2022 | 35949853 | PubTator, text mining | PubMed |
| The role of macrophages phenotypes in the activation of resolution pathways within human granulosa cells. | Reprod Biol Endocrinol | 2022 | 35948935 | PubTator, text mining | PubMed |
| Spatial multi-omic map of human myocardial infarction. | Nature | 2022 | 35948637 | PubTator, text mining | PubMed |
| Pre-existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients. | Clin Transl Discov | 2022 | 35942236 | PubTator, text mining | PubMed |
| Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer. | Front Immunol | 2022 | 35935996 | PubTator, text mining | PubMed |
| Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma. | Front Immunol | 2022 | 35935940 | PubTator, text mining | PubMed |
| Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis. | Front Pharmacol | 2022 | 35935869 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=61